Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

SBIR grant supports development of modified annexin V

Oct. 29, 2003

Positive opinion handed down by CPMP for Advate

Oct. 27, 2003

Novel antiplatelet/antithrombotic agent acting through the L-arginine/NO pathway

Oct. 23, 2003

New factor Xa inhibitors covered by Curacyte patent

Oct. 21, 2003

Archemix selects ARC-183 for development

Oct. 20, 2003

Merck KGaA team discovers new integrin inhibitors for thrombosis, cardiovascular disorders, etc.

Oct. 14, 2003

Merck KGaA scientists discover new factor Xa/factor VIIa inhibitors

Oct. 9, 2003

Successful interim analysis of phase II alfimeprase study

Sep. 30, 2003

OBI-1 undergoes testing in hemophilia A patients

Sep. 30, 2003

Novel TF/factor VIIa inhibitors under study at Roche

Sep. 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...